Search

everythinglearnresearchcommunity

for

Search:↓

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Using body hair with scalp hair for hair transplants improves density and coverage in severe hair loss cases.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

The Graft Quality Index grades hair transplant grafts to predict placement difficulty and surgery results.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

Androgenic alopecia (AA) in Indian women is rarely reported, with varying severity and patterns, and hair pull tests and trichograms help understand it better.

Implant safely and effectively treats hair loss.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Lifestyle changes like diet and exercise are crucial for managing PCOS.

Hair restoration surgery has improved with better techniques for natural looks and managing patient expectations, but it remains labor-intensive and requires careful consideration of potential complications.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Hair loss on the lower legs is common in middle-aged men, usually harmless, and doesn't need treatment.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.